Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameTrinity Capital Inc
-
Registration countryUSA
-
IndustryOther Financial Institutions
-
М/S&P/F
*** /*** /***









